Skip to main content
  • Zika Updates

    Monday, June 20, 2016

    The following information has been added to or recently updated on the CDC Zika and CDC Travelers' Health sites.

    Read More
  • Zecuity (sumatriptan) Migraine Patch: Drug Safety Communication - FDA Evaluating Risk of Burns and Scars

    Thursday, June 2, 2016

    FDA is investigating the risk of serious burns and potential permanent scarring with the use of Zecuity (sumatriptan iontophoretic transdermal system) patch for migraine headaches. Since marketing of the Zecuity patch began in September 2015, a large number of patients have reported they experienced burns or scars on the skin where the patch was worn.

    Read More